University of Florida College of Pharmacy researchers studying the safety of two classes of drugs touted as potential therapeutics for COVID-19 report mixed results.
UF Health researchers begin developing an at-home test for coronavirus.
Christina Boucher, Ph.D., associate professor in the UF Department of CISE, has received a $1.2 million grant from the NSF.
Meanwhile, an internal report by the Centers for Disease Control and Prevention concluded the delta variant is as contagious as chickenpox and more transmissible than the viruses that cause seasonal flu, the common cold and Ebola.
A team of virologists who study viruses in bats work toward a test for a public health study to understand its development in older adults.
Many Americans are simply touching their faces too often during the novel coronavirus pandemic, public health officials have observed, potentially increasing their exposure to the pathogen.
Thirty UF faculty members and students answered the call when the state of Florida needed to drastically boost the number of epidemiologists working with health departments around the state.
A trio of interdisciplinary UF researchers are searching for genes that either hasten or thwart the growth of SARS-CoV-2 virus inside a human host. Their results may contribute to the search for a COVID-19 drug or therapeutic arsenal.
UF investigators participate in the first study to determine that the CoronaVac vaccine is 50% effective at preventing COVID-19 in Manaus, Brazil where the P.1 variant is widespread.
Never before had the world looked as it had in the spring of 2020, when the start of the coronavirus pandemic convened a number of unusual circumstances all at once.
Researchers from across the University of Florida and UF Health have joined an urgent effort to collect and donate personal protective equipment, or PPE, to build upon existing stockpiles in support of clinical colleagues on the frontlines of treating COVID-19.
“You need large numbers and multiple products in many different settings tested in many different kinds of people to assess whether they’re really safe and effective,” said Ira Longini, a professor at UF PHHP and UF Medicine.